Results 121 to 130 of about 26,835 (181)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents [PDF]

, 2017
Abraham, Christopher, Acharya, Sahaja, Chicoine, Michael, Dowling, Joshua, Dunn, Gavin, Huang, Jiayi, Keller, Jesse, Leuthardt, Eric, Mahmood, Mustafaa, Mullen, Daniel, Perkins, Stephanie M, Rich, Keith, Robinson, Clifford G, Tsien, Christina I, Yang, Deshan   +14 more
core   +2 more sources

BRAF and MEK inhibition beyond dabrafenib-trametinib in advanced thyroid cancer: a real-world case series. [PDF]

Front Endocrinol (Lausanne)
Yamin T, Cohen O, Robenshtok E, Izkhakov E, Miodovnik M, Gutfeld O, Leshem Y, Meirovitz R, Warshavsky A, Muhanna N, Finkel I.   +10 more
europepmc   +1 more source

Pathway-Specific Therapeutic Modulation of Melanoma: Small-Molecule Inhibition of BRAF-MEK and KIT Signaling in Contemporary Precision Oncology with a Special Focus on Vemurafenib, Trametinib, and Imatinib. [PDF]

J Clin Med
Kawczak P, Bączek T.
europepmc   +1 more source

Fyn inhibition by TAE684: A synergistic strategy to suppress melanoma and reverse vemurafenib resistance. [PDF]

Cell Death Dis
Liu W, Zhang X, Liang X, Guo Y, Zhou Z, Zhu S, Peng C, Chen X.   +7 more
europepmc   +1 more source

A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibition. [PDF]

Oncogene
Riordan JD, Nathanson TA, Varzavand A, Hawkins AA, Peplinski RM, Hannan EC, Bibeau FA, Freesmeier NJ, Jilek MC, Coma S, Pachter JA, Dupuy AJ, Stipp CS.   +12 more
europepmc   +1 more source

Design, synthesis and antiproliferative, apoptotic, and immunomodulatory properties of new heteroaryl pyridine-linked 1,2,4-oxadiazoles as prospective dual EGFR/BRAF^V600E inhibitors. [PDF]

RSC Adv
Gomaa HAM, Shaker ME, Alzarea SI, Alatwi E, Mohamed FAM, Abdullah Alzahrani AY, Alyami BA, Bräse S, Rabea SM, Youssif BGM.   +9 more
europepmc   +1 more source

Cellular and Molecular Effects of Targeting the CBP/β-Catenin Interaction with PRI-724 in Melanoma Cells, Drug-Naïve and Resistant to Inhibitors of BRAF^V600 and MEK1/2. [PDF]

Cells
Gajos-Michniewicz A, Wozniak M, Kluszczynska KA, Czyz M.   +3 more
europepmc   +1 more source

Systemic Molecularly Targeted Therapies for Neoadjuvant and Salvage Craniopharyngioma: A Contemporary Narrative Review. [PDF]

Biomedicines
Neubecker JJ, Griepp DW, Turnbull JP, Caskey J, Desai S, Mansour A, Ahmed R, Beggs A, Griepp ATK, Heitkotter H, Claus CF, Richards BF, Kelkar PS.   +12 more
europepmc   +1 more source

Delayed Neurologic Response to Dabrafenib and Trametinib in the Case of Mixed Histiocytosis (LCH/ECD): Case Report and Literature Review. [PDF]

Reports (MDPI)
Imashuku S, Kobayashi M, Miyoshi T, Anzai N.   +3 more
europepmc   +1 more source

Sustained Response to Pan-BRAF Inhibitor Plixorafenib (FORE8394, PLX8394) in a Young Adult With Neurodegenerative Langerhans Cell Histiocytosis. [PDF]

JCO Precis Oncol
Yi JS, McCarthy KS, Mazur K, Kudlaty R, Armstrong T, Desai N, Shepherd SP, Zinn D, Velazquez J, Scull B, Allen C, McClain K.   +11 more
europepmc   +1 more source